74 Genetic Locations Linked to Anxiety Identified

A groundbreaking genome-wide association study (GWAS), the most extensive of its kind to date, has shed new light on the intricate genetic architecture underpinning anxiety. By analyzing the genomic profiles of nearly 700,000 individuals, this research transcends traditional diagnostic categories, focusing instead on the continuous spectrum of anxiety symptom severity. This novel approach has allowed scientists to identify 74 distinct genetic locations associated with anxiety, significantly advancing our understanding of this widespread mental health challenge.

Breakthrough in Anxiety Genetics: New Insights into Neural Pathways and Environmental Factors

In a significant scientific endeavor, researchers at King's College London and QIMR Berghofer medical research institute embarked on the largest genome-wide association study (GWAS) focused on anxiety. Published on June 9, 2026, in the esteemed journal Nature Human Behaviour, their findings represent a monumental step forward in comprehending the genetic underpinnings of anxiety. The study meticulously analyzed genetic data from 693,869 individuals of European ancestry, moving beyond binary clinical diagnoses to investigate the continuous spectrum of anxiety symptoms.

This pioneering research successfully pinpointed 74 distinct genomic locations correlated with anxiety, an astonishing 39 of which are entirely new discoveries. These identified genes, notably including PCLO and SORCS3, demonstrate high activity within brain tissue, playing crucial roles in the intricate process of neural communication. This suggests that variations in synaptic transmission directly influence an individual's vulnerability to anxiety. Professor Thalia Eley, a lead author from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, emphasized the importance of this work, stating, "Despite the public health impact of anxiety, progress in the understanding of its genetics lags behind other major mental health conditions." She expressed hope that these findings would stimulate further large-scale analyses to unravel anxiety's genetic architecture.

The study also revealed that common genetic variations account for approximately 6% of the differences in anxiety symptom severity among individuals. This leaves a substantial portion of variance to be influenced by environmental stressors, life experiences, and complex gene-environment interactions. Dr. Megan Skelton, the first author from IoPPN, King's College London, highlighted that "the rise in anxiety rates points to environmental factors, as genetics don't change much across generations." This underscores the critical need to address societal and environmental triggers to mitigate rising anxiety levels, particularly among young adults.

Furthermore, the researchers developed polygenic scores for anxiety, which, though primarily based on European-ancestry data, showed significant associations in African and South Asian populations. This indicates shared genetic influences but also signals the urgent requirement for more diverse biobank data to create accurate, population-specific risk models. The analysis also uncovered broad genetic correlations between anxiety and various mental and physical health conditions, including depression, irritable bowel syndrome, chronic pain, coronary artery disease, endometriosis, and migraines. Dr. Brittany Mitchell from the QIMR Berghofer medical research institute noted that these correlations underscore the profound interconnection between mental and physical well-being, paving the way for future research into causality and therapeutic interventions. This extensive study, partially funded by the US National Institute for Health (NIH) and supported by various other bodies, significantly advances our understanding of anxiety's complex etiology, offering new avenues for early screening and targeted treatments.

This study marks a pivotal moment in psychiatric genetics, shifting the paradigm from rigid diagnostic categories to a nuanced understanding of anxiety as a biological continuum. By focusing on symptom severity, researchers have uncovered a wealth of genetic insights that were previously obscured. The identification of specific genes involved in neural communication provides clear targets for future drug development and personalized interventions. However, the study also powerfully reminds us that while genetics lay a foundation, environmental and societal factors are profoundly shaping the global landscape of mental health. The findings highlight the critical need for comprehensive approaches that integrate genetic understanding with environmental considerations, ensuring that prevention and treatment strategies are both biologically informed and socially responsive. Furthermore, the emphasis on diversifying genomic datasets for polygenic risk scores underscores a crucial ethical and scientific imperative to ensure that advancements in genetic research benefit all populations equitably.